Infective Endocarditis Clinical Trials

12 recruiting

Infective Endocarditis Trials at a Glance

12 actively recruiting trials for infective endocarditis are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Paris, Bordeaux, and Clermont-Ferrand. Lead sponsors running infective endocarditis studies include Assistance Publique - Hôpitaux de Paris, Central Hospital, Nancy, France, and Assiut University.

Browse infective endocarditis trials by phase

Treatments under study

About Infective Endocarditis Clinical Trials

Looking for clinical trials for Infective Endocarditis? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infective Endocarditis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infective Endocarditis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.

Patient ParticipationBacterial InfectionsInfective Endocarditis+1 more
Region Halland50 enrolled1 locationNCT06704048
Recruiting
Not Applicable

CBCT vs OPT on the Oral Health Status at 12 Months of Patients Hospitalized for Infective Endocarditis.

Infective Endocarditis
Nantes University Hospital170 enrolled10 locationsNCT06269679
Recruiting
Phase 2

Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

Infective Endocarditis
University Hospital, Bordeaux40 enrolled1 locationNCT05446376
Recruiting

Betalactam Pharmacokinetics in Endocarditis Patients

Infective Endocarditis
Uppsala University150 enrolled4 locationsNCT04647331
Recruiting
Not Applicable

Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

Staphylococcus AureusBacteremiaInfective Endocarditis
Assistance Publique - Hôpitaux de Paris700 enrolled1 locationNCT06457386
Recruiting

Prospective Cohort Study of Patients With Infective Endocarditis at Pitié-Salpêtrière Hospital

Infective Endocarditis
Assistance Publique - Hôpitaux de Paris700 enrolled1 locationNCT04992923
Recruiting

French National Observatory on Infective Endocarditis

Infective Endocarditis
Central Hospital, Nancy, France5,000 enrolled1 locationNCT03272724
Recruiting
Not Applicable

Reducing Risk for Infective Endocarditis

BacteremiaInfective Endocarditis
Wake Forest University Health Sciences320 enrolled6 locationsNCT05721781
Recruiting

Barts Endocarditis Research Registry

EndocarditisInfective EndocarditisEndocarditis, Bacterial
Queen Mary University of London1,000 enrolled1 locationNCT06434012
Recruiting

Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis

Infective EndocarditisNative Valve Endocarditis
Montreal Heart Institute97 enrolled6 locationsNCT04792281
Recruiting

Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR)

Infective Endocarditis
First Affiliated Hospital Xi'an Jiaotong University2,000 enrolled1 locationNCT05965362
Recruiting

The Incidence, Clinical Characteristics and Outcome of Infective Endocarditis Among Intravenous Drug Abusers Versus Non-Drug Abusers.

Infective Endocarditis
Assiut University46 enrolled1 locationNCT06194409